| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding | |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | Entrez:3563 MIM:308385 MIM:430000 HGNC:HGNC:6012 Ensembl:ENSG00000185291 Ensembl:ENSG00000292332 AllianceGenome:HGNC:6012 | |
| Description | interleukin 3 receptor subunit alpha | |||||
| GTO ID | GTC2287 |
| Trial ID | NCT04230265 |
| Disease | Acute Myeloid Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UniCAR02-T-CD123 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies |
| Year | 2020 |
| Country | Germany |
| Company sponsor | AvenCell Europe GmbH |
| Other ID(s) | UC02-123-01|2019-001339-30 |
| Cohort 1 | |||||||||
|
|||||||||